RenovoRx, Inc.
RNXT· Nasdaq
Released Mar 31, 2025, after the close
10-K filed Apr 1, 2025, 91 days after period end · 0001641172-25-001932
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$2.88M | -$3.23M | -$2.16M | -$2.36M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
RenovoRx, Inc. · CIK 1574094 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Dec 31, 2024 · filed Apr 1, 2025 · 91 d after period end
3.0% from the close of Mar 31, 2025 to the close of Apr 1, 2025, the first after the release.